Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Entamoeba histolytica

Adrienne J. Showler and Andrea K. Boggild
CMAJ September 03, 2013 185 (12) 1064; DOI: https://doi.org/10.1503/cmaj.121576
Adrienne J. Showler
Department of Medicine (Showler, Boggild), University of Toronto; Public Health Ontario Laboratories (Boggild), Public Health Ontario; Tropical Disease Unit, Division of Infectious Diseases (Boggild), University Health Network Toronto General Hospital, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea K. Boggild
Department of Medicine (Showler, Boggild), University of Toronto; Public Health Ontario Laboratories (Boggild), Public Health Ontario; Tropical Disease Unit, Division of Infectious Diseases (Boggild), University Health Network Toronto General Hospital, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: andrea.boggild@utoronto.ca
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

The gastrointestinal pathogen Entamoeba histolytica causes amoebiasis

Clinical severity ranges from the asymptomatic passage of cysts in the stool to fulminant dysentery. Potentially fatal extraintestinal amoebiasis, including amoebic liver abscess, complicates 1%–3% of infections.1 Pregnancy, immunocompromise, corticosteroid use, alcohol abuse and diabetes are risk factors for severe disease.2 Transmission can be sexual or occur via fecal contamination of food and water.3 Most infections are acquired abroad in tropical and subtropical areas,4 although household contacts of a patient with this infection, men who have sex with men and residents of institutions are also at risk.3

Standard stool examinations for ova and parasites cannot reliably distinguish pathogenic E. histolytica from nonpathogenic Entamoeba dispar

Stool microscopy reports typically state “Entamoeba histolytica/dispar present.” Although morphologically identical to E. histolytica, E. dispar is a nonpathogenic intestinal amoeba. False-negative result rates for stool microscopy approach 40%, but decrease to 5%–15% with 3 or more specimens examined.1 Testing to confirm E. histolytica by polymerase chain reaction or enzyme immunoassay should be done on a separate, fresh and unpreserved specimen.5 In developed countries, the prevalence of E. histolytica/E. dispar is 2.4% among immigrants, 4% among travellers and 27% among men who have sex with men.4 Most cases represent E. dispar colonization; in 1 Canadian study, only 4.6% of cases involved E. histolytica.4

Infection with E. histolytica requires treatment; colonization with E. dispar does not

Entamoeba histolytica is a nationally and provincially notifiable disease; E. dispar is a harmless commensal with no public health implications. Colonization of the stool with E. dispar suggests potential exposure to other pathogens with fecal–oral transmission but does not cause diarrhea.

Empiric treatment is rarely warranted

Current guidelines recommend treatment only when E. histolytica is identified, or if dysentery of unknown cause persists despite empiric treatment of Shigella with consecutive 2-day courses of different antibiotic agents.6 Suspicion of amoebic liver abscess based on epidemiology and characteristic imaging should prompt empiric treatment.2

Invasive disease requires dual therapy

Symptomatic amoebiasis requires a 2-drug regimen: an amoebicidal agent, such as metronidazole, and a luminal-acting cysticidal agent, such as iodoquinol.7 A recent meta-analysis concluded that monotherapy is inadequate for most cases of amoebiasis.7 Asymptomatic cyst passage is treated with a luminal cysticide to prevent transmission and progression to invasive disease. A summary of therapeutic options is shown in Appendix 1 (available at www.cmaj.ca/lookup/suppl/doi:10.1503/cmaj.121576/-/DC1).

References

  1. ↵
    1. Fotedar R,
    2. Stark D,
    3. Beebe N,
    4. et al
    . Laboratory diagnostic techniques for Entamoeba species. Clin Microbiol Rev 2007;20:532–34.
    OpenUrl
  2. ↵
    1. Stanley SL
    . Amoebiasis. Lancet 2003;361:1025–34.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Salit IE,
    2. Khairnar K,
    3. Gough K,
    4. et al
    . A possible cluster of sexually transmitted Entamoeba histolytica: genetic analysis of a highly virulent strain. Clin Infect Dis 2009;49:346–53.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Pillai DR,
    2. Keystone JS,
    3. Sheppard DC,
    4. et al
    . Entamoeba histolytica and Entamoeba dispar: epidemiology and comparison of diagnostic methods in a setting of non-endemicity. Clin Infect Dis 1999;29: 1315–8.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    World Gastroenterology Organisation global guidelines. Acute diarrhea in adults and children: a global perspective. Milwaukee (WI): the Organisation; 2012. Available: www.worldgastroenterology.org/acute-diarrhea-in-adults.html (accessed 2013 Feb. 8).
  6. ↵
    1. Garcia LS,
    2. Smith JW,
    3. Fritsche TR
    . Cumitech 30A — selection and use of laboratory procedures for diagnosis of parasitic infections of the gastrointestinal tract. Garcia LS, coordinating editor. Washington (DC): ASM Press; 2003.
  7. ↵
    1. Gonzales MLM,
    2. Dans LF,
    3. Martinez EG
    . Anti-amoebic drugs for treating amoebic colitis. Cochrane Database Syst Rev 2009; (2):CD006085.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 185 (12)
CMAJ
Vol. 185, Issue 12
3 Sep 2013
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Entamoeba histolytica
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Entamoeba histolytica
Adrienne J. Showler, Andrea K. Boggild
CMAJ Sep 2013, 185 (12) 1064; DOI: 10.1503/cmaj.121576

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Entamoeba histolytica
Adrienne J. Showler, Andrea K. Boggild
CMAJ Sep 2013, 185 (12) 1064; DOI: 10.1503/cmaj.121576
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • The gastrointestinal pathogen Entamoeba histolytica causes amoebiasis
    • Standard stool examinations for ova and parasites cannot reliably distinguish pathogenic E. histolytica from nonpathogenic Entamoeba dispar
    • Infection with E. histolytica requires treatment; colonization with E. dispar does not
    • Empiric treatment is rarely warranted
    • Invasive disease requires dual therapy
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The monkeypox virus
  • Vitamin B12 deficiency
  • Costochondral gout
Show more Practice

Similar Articles

Collections

  • Article Types
    • Five Things to Know About
  • Topics
    • Infectious diseases
    • Travel medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire